AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
Carlotta Antoniotti
◽
Beatrice Borelli
◽
Daniele Rossini
◽
Filippo Pietrantonio
◽
Federica Morano
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS189-TPS189
L. S. Schwartzberg
◽
V. J. Wagner
2012 ◽
Vol 23
◽
pp. xi131
Y. Miyata
◽
T. Nishina
◽
T. Kato
◽
K. Yamazaki
◽
T. Yoshino
◽
...
K. Ding
◽
Y. Liu
◽
J. Chen
◽
J. Ying
◽
Q. Xu
◽
...
2018 ◽
Vol 29
◽
pp. v108
◽
K. Lesniewski-Kmak
◽
V. Moiseenko
◽
M. Saunders
◽
H. Wasan
◽
G. Argiles
◽
...
2015 ◽
Vol 76
(3)
◽
pp. 547-553
◽
Tomohiro Nishina
◽
Takeshi Kato
◽
Kentaro Yamazaki
◽
Takayuki Yoshino
◽
Yoshinori Miyata
◽
...
2020 ◽
Vol 26
(14)
◽
pp. 3557-3564
Richard D. Kim
◽
Nilofer S. Azad
◽
Michael A. Morse
◽
Elizabeth Poplin
◽
Amit Mahipal
◽
...
2006 ◽
Vol 93
(5)
◽
pp. 387-393
◽
Robert C.G. Martin
◽
Charles R. Scoggins
◽
Kelly M. Mc Masters
K. Ding
◽
Y. Liu
◽
J. Du
◽
Y. Zhu
◽
D. Xu
◽
...
2012 ◽
Vol 103
(8)
◽
pp. 1502-1507
◽
Yasushi Tsuji
◽
Taroh Satoh
◽
Akihito Tsuji
◽
Kei Muro
◽
Motoki Yoshida
◽
...
Close
Export Citation Format
Close
Share Document
Close